Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_assertion description "[Prompted by this finding and because RAS/RAF/MEK mutations are known mediators of acquired resistance in other solid tumors (colon cancers, gastrointestinal stromal tumors, and melanomas) responsive to targeted therapies, we analyzed the frequency of secondary KRAS/NRAS/BRAF/MEK1 gene mutations in the largest collection to date of lung cancers with acquired resistance to EGFR TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_assertion evidence source_evidence_literature NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_assertion SIO_000772 22773810 NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_assertion wasDerivedFrom befree-2016 NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_assertion wasGeneratedBy ECO_0000203 NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.
- befree-2016 importedOn "2016-02-19" NP996106.RA2l-9G9UWdUGviySGBC2nWBr_a31hBS4FoN0yeQR9nps130_provenance.